Melting the <i>eis</i>: Nondetection of Kanamycin Resistance Markers by Routine Diagnostic Tests and Identification of New <i>eis</i> Promoter Variants
Ley SD, Pillay S, Streicher EM, van der Heijden YF, Sirgel F, Derendinger B, de Kock M, Gagneux S, et al. (11 authors)
Antimicrobial agents and chemotherapy · 2021-06
Abstract
Eis promoter mutations can confer reduced Mycobacterium tuberculosis kanamycin susceptibility. GenoType MTBDR sl, a widely used assay evaluating this region, wrongly classified 17/410 isolates as eis promoter wild type. Six out of seventeen isolates harbored mutations known to confer kanamycin resistance, and the remainder harbored either novel eis promoter mutations (7/11) or disputed mutations (4/11). GenoType MTBDR sl can miss established and new variants that cause reduced susceptibility. These data highlight the importance of reflex phenotypic kanamycin testing.
MeSH terms
- Humans
- Mycobacterium tuberculosis
- Tuberculosis, Multidrug-Resistant
- Kanamycin
- Antitubercular Agents
- Diagnostic Tests, Routine
- Microbial Sensitivity Tests
- Drug Resistance, Multiple, Bacterial
- Kanamycin Resistance
- Genotype
- Mutation